Related Experiment Video
Updated: May 25, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Is 8860 variation a rare polymorphism or associated as a secondary effect in HCM disease?
Massoud Houshmand1, Maryam Montazeri, Nafiseh Kuchekian
1National Institute for Genetic Engineering and Biotechnology, Tehran, Iran.
Insights
Mitochondrial DNA (mtDNA) point mutations, not deletions, were identified in Iranian hypertrophic cardiomyopathy (HCM) patients. A specific A8860G transition was frequently observed, suggesting a potential secondary role in HCM development.
Area of Science:
- Cardiology
- Genetics
- Mitochondrial Biology
Background:
- Mitochondrial DNA (mtDNA) defects are linked to hypertrophic cardiomyopathies.
- Hypertrophic cardiomyopathy (HCM) is a complex, multifactorial cardiac condition.
- Mitochondrial dysfunction may contribute to the pathogenesis of certain HCM forms.
Purpose of the Study:
- To determine the spectrum of mtDNA mutations in Iranian patients with hypertrophic cardiomyopathy.
- To investigate the prevalence of specific mtDNA hot spot region mutations in HCM.
Main Methods:
- Mitochondrial DNA (mtDNA) point mutations and deletions were analyzed.
- Polymerase Chain Reaction (PCR) and sequencing were employed for mutation detection.
- A control group of individuals without cardiac disease was included for comparison.
Main Results:
- Several previously unreported mtDNA point mutations were identified in HCM patients.
- No mtDNA deletions were detected in the study cohort.
- Some identified point mutations were investigated in HCM patients for the first time.
Conclusions:
- The A8860G transition was found in a significant proportion of HCM patients.
- This finding raises questions about the potential secondary association of this rare polymorphism with HCM.
- Further research is needed to elucidate the role of specific mtDNA mutations in HCM etiology.
Introduction:
mtDNA defects, both deletions and point mutations, have been associated with hypertrophic cardiomyopathies. The aim of this study was to establish a spectrum for mtDNA mutations in Iranian hypertrophic cardiomyopathy (HCM) patients.
Material And Methods:
The control group was chosen among the special medical centre visitors who did not have hypertrophic cardiomyopathy or any related heart disease. Hypertrophic cardiomyopathy (HCM) is widely accepted as a pluricausal or multifactorial disease. Because of the linkage between energy metabolism in the mitochondria and cardiac muscle contraction, it is reasonable to assume that mitochondrial abnormalities may be responsible for some forms of HCM. Point mutations and deletions in the two hot spot regions of mtDNA were investigated by PCR and sequencing methods.
Results:
Some unreported point mutations have been found in this study but no deletion was detected. Meanwhile some of these point mutations have been investigated among HCM patients for the first time.
Conclusions:
A8860G transition was detected in a high proportion, raising the question whether this rare polymorphism is associated as a secondary effect in HCM disease.
More Related Videos
06:02An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Genetic Lingo
Multiple Allele Traits
Cardiomyopathy I: Introduction and Classification
Huntington Disease l: Introduction
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...